查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869928

RNA分析市场规模、份额和趋势分析报告：按产品、技术、应用、最终用途、地区和细分市场进行预测

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End Use, By Region, And Segment Forecasts
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

RNA分析市场摘要

2024年全球RNA分析市场规模估计为86.2亿美元，预计2033年将达到236.5亿美元。

预计从 2025 年到 2033 年，该产业将以 12.55% 的复合年增长率成长。这一增长是由精准医疗中对转录组研究的需求不断增长、次世代定序(NGS) 技术的进步以及 RNA 生物标誌物在疾病诊断和药物发现中应用范围的扩大所驱动的。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析

第四章 产品业务分析

  • 产品细分仪表板
  • 全球RNA分析市场：产品差异分析
  • 全球RNS分析市场规模及趋势分析（依产品划分，2021-2033年）
  • 装置
  • 试剂盒和试剂
    • miRNA和siRNA
    • 逆转录酶和RT-PCR
    • RNA萃取与纯化
    • RNA干扰
    • 其他的
  • 服务

第五章：技术业务分析

  • 技术细分仪表板
  • 全球RNA分析市场：技术差异分析
  • 全球RNS分析市场规模及趋势分析（依技术划分，2021-2033年）
  • 即时PCR（qPCR）
  • 微阵列
  • 定序
  • 其他的

第六章：应用业务分析

  • 应用细分仪表板
  • 全球RNA分析市场：应用差异分析
  • 全球RNS分析市场规模及趋势分析（依应用领域划分，2021-2033年）
  • 建构RNA表现图谱
  • 表观遗传学
  • 感染疾病与发病机制
  • RNA选择性剪接
  • RNA结构与分子动力学
  • RNA疗法的开发和提供
  • 其他的

第七章 最终使用者业务分析

  • 最终用户细分仪表板
  • 全球RNA分析市场：最终用途变异性分析
  • 全球RNS分析市场规模及趋势分析（依最终用途划分），2021-2033年
  • 政府机构及学术中心
  • 製药和生物技术公司
  • 医院和诊所
  • 合约研究组织（CRO）

第八章 区域业务分析

  • 2022年及2033年各地区RNA分析市占率
  • 北美洲
    • 2021-2033年北美RNA分析市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲RNA分析市场，2021-2033年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区RNA分析市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲RNA分析市场，2021-2033年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东及非洲RNA分析市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 公司分类
  • 策略规划
  • 企业定位分析，2024
  • 公司简介
    • Agilent Technologies, Inc
    • F. Hoffmann-La Roche AG
    • Illumina, Inc.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Eurofins Scientific
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Pacific Bioscience of California, Inc.;
    • Affymetrix, Inc.
    • Danaher
    • Promega
Product Code: 978-1-68038-534-2

RNA Analysis Market Summary

The global RNA analysis market size was estimated at USD 8.62 billion in 2024 and is projected to reach USD 23.65 billion by 2033, growing at a CAGR of 12.55% from 2025 to 2033. This growth is driven by the rising demand for transcriptomic studies in precision medicine, advancements in next-generation sequencing (NGS) technologies, and increasing applications of RNA biomarkers in disease diagnostics and drug discovery.

Global RNA Analysis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global RNA analysis market on the basis of product, technology, application, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Kits & Reagents
    • miRNA & siRNA
    • Reverse Transcriptases & RT-PCR
    • RNA Extraction & Purification
    • RNA Interference
    • Others
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Real Time-PCR (qPCR)
  • Microarray
  • Sequencing
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Construction of RNA expression atlas
  • Epigenetics
  • Infectious diseases and pathogenesis
  • Alternative RNA splicing
  • RNA structure and molecular dynamics
  • Development and delivery of RNA therapeutics
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract research Organizations (CROs)
  • Hospitals & Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Technology
    • 1.1.3. Application
    • 1.1.4. End Use
  • 1.2. Market Definitions
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Others
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advances in sequencing technologies
      • 3.2.1.2. Drug development and vaccine research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Higher Cost of Research & Developments
      • 3.2.2.2. High Costs Associated With Analysis Platforms
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global RNA Analysis Market: Product Movement Analysis
  • 4.3. Global RNS Analysis Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
  • 4.5. Kits & Reagents
    • 4.5.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
    • 4.5.2. miRNA & siRNA
      • 4.5.2.1. miRNA & siRNA Market, 2021 - 2033 (USD Million)
    • 4.5.3. Reverse Transcriptases & RT-PCR
      • 4.5.3.1. Reverse Transcriptases & RT-PCR Market, 2021 - 2033 (USD Million)
    • 4.5.4. RNA Extraction & Purification
      • 4.5.4.1. RNA Extraction & Purification Market, 2021 - 2033 (USD Million)
    • 4.5.5. RNA Interference
      • 4.5.5.1. RNA Interference Market, 2021 - 2033 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Other Kits & Reagents Market, 2021 - 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Global RNA Analysis Market: Technology Movement Analysis
  • 5.3. Global RNS Analysis Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Real Time-PCR (qPCR)
    • 5.4.1. Real Time-PCR (qPCR) Market, 2021 - 2033 (USD Million)
  • 5.5. Microarray
    • 5.5.1. Microarray Market, 2021 - 2033 (USD Million)
  • 5.6. Sequencing
    • 5.6.1. Sequencing Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Other Technologies Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global RNA Analysis Market: Application Movement Analysis
  • 6.3. Global RNS Analysis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Construction of RNA Expression Atlas
    • 6.4.1. Construction of RNA Expression Atlas Market, 2021 - 2033 (USD Million)
  • 6.5. Epigenetics
    • 6.5.1. Epigenetics Market, 2021 - 2033 (USD Million)
  • 6.6. Infectious Diseases & Pathogenesis
    • 6.6.1. Infectious Diseases & Pathogenesis Market, 2021 - 2033 (USD Million)
  • 6.7. Alternative RNA Splicing
    • 6.7.1. Alternative RNA Splicing Market, 2021 - 2033 (USD Million)
  • 6.8. RNA Structure & Molecular Dynamics
    • 6.8.1. RNA Structure & Molecular Dynamics Market, 2021 - 2033 (USD Million)
  • 6.9. Development & Delivery of RNA Therapeutics
    • 6.9.1. Development & Delivery of RNA Therapeutics Market, 2021 - 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global RNA Analysis Market: End Use Movement Analysis
  • 7.3. Global RNS Analysis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Government Institutes & Academic Centers
    • 7.4.1. Government Institutes & Academic Centers Market, 2021 - 2033 (USD Million)
  • 7.5. Pharmaceutical & Biotechnology Companies
    • 7.5.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 7.6. Hospitals & Clinics
    • 7.6.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 7.7. Contract Research Organizations (CROs)
    • 7.7.1. Contract Research Organizations (CROs) Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. RNA Analysis Market Share By Region, 2022 & 2033
  • 8.2. North America
    • 8.2.1. North America RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. U.S. RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Canada RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Mexico RNA Analysis Market, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. UK RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Germany RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. France RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Italy RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Spain RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Denmark RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Sweden RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Norway RNA Analysis Market, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Japan RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. China RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. India RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Australia RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Thailand RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. South Korea RNA Analysis Market, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Brazil RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Argentina RNA Analysis Market, 2021 - 2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. South Africa RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Saudi Arabia RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. UAE RNA Analysis Market, 2021 - 2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Kuwait RNA Analysis Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Agilent Technologies, Inc
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. F. Hoffmann-La Roche AG
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Illumina, Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. QIAGEN
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Thermo Fisher Scientific, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Eurofins Scientific
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Bio-Rad Laboratories, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Pacific Bioscience of California, Inc.;
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Affymetrix, Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Danaher
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Promega
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global RNA analysis market, by product, 2021 - 2033 (USD Million)
  • Table 3 Global RNA analysis market, by technology, 2021 - 2033 (USD Million)
  • Table 4 Global RNA analysis market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global RNA analysis market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Global RNA analysis market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 8 North America RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 9 North America RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 10 North America RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 13 U.S. RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 14 U.S. RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 15 Canada RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 16 Canada RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 17 Canada RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 18 Canada RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 19 Mexico RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 20 Mexico RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 21 Mexico RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 22 Mexico RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 23 Europe RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 24 Europe RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 25 Europe RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 26 Europe RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 28 Germany RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 29 Germany RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 30 Germany RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 31 U.K. RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 32 U.K. RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 33 U.K. RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 34 U.K. RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 35 France RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 36 France RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 37 France RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 38 France RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 39 Italy RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 40 Italy RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 41 Italy RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 42 Italy RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 43 Spain RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 44 Spain RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 45 Spain RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 46 Spain RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 47 Denmark RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 48 Denmark RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 49 Denmark RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 50 Denmark RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 51 Sweden RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 52 Sweden RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 53 Sweden RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 54 Sweden RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 55 Norway RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 56 Norway RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 57 Norway RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 58 Norway RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 63 China RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 64 China RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 65 China RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 66 China RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 67 Japan RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 68 Japan RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 69 Japan RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 70 Japan RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 71 India RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 72 India RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 73 India RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 74 India RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 75 Australia RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 76 Australia RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 77 Australia RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 78 Australia RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 79 Thailand RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 80 Thailand RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 81 Thailand RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 82 Thailand RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 83 South Korea RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 84 South Korea RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 85 South Korea RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 86 South Korea RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 87 Latin America RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 88 Latin America RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 89 Latin America RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 90 Latin America RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 91 Brazil RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 92 Brazil RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 93 Brazil RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 94 Brazil RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 95 Argentina RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 96 Argentina RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 97 Argentina RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 98 Argentina RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 99 MEA RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 100 MEA RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 101 MEA RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 102 MEA RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 103 South Africa RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 104 South Africa RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 105 South Africa RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 106 South Africa RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 111 UAE RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 112 UAE RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 113 UAE RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 114 UAE RNA analysis market by end use, 2021 - 2033 (USD Million)
  • Table 115 Kuwait RNA analysis market by product, 2021 - 2033 (USD Million)
  • Table 116 Kuwait RNA analysis market by technology, 2021 - 2033 (USD Million)
  • Table 117 Kuwait RNA analysis market by application, 2021 - 2033 (USD Million)
  • Table 118 Kuwait RNA analysis market by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 RNA analysis market segmentation
  • Fig. 7 Market snapshot, 2024
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 PESTEL analysis
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 RNA analysis market: Products outlook and key takeaways
  • Fig. 14 RNA analysis market: Product movement analysis
  • Fig. 15 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Kits & reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 miRNA and siRNA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Reverse transcriptase & RT-PCR market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 RNA extraction & purification market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 RNA interference market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Others kits & reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 RNA analysis market: Technology outlook and key takeaways
  • Fig. 24 RNA analysis market: Technology movement analysis
  • Fig. 25 Real time-PCR (qPCR) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Microarray market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Other technologies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 RNA analysis market: Application outlook and key takeaways
  • Fig. 30 RNA analysis Market: Application movement analysis
  • Fig. 31 Construction of RNA expression atlas market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Epigenetics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Infectious diseases and pathogenesis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Alternative RNA splicing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 RNA structure and molecular dynamics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Development and delivery of RNA therapeutics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Others applications market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 RNA analysis market: End Use outlook and key takeaways
  • Fig. 39 RNA analysis market: End Use movement analysis
  • Fig. 40 Government institutes & academic centers estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Pharmaceutical & biotechnology companies estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Hospitals & clinics estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Contract Research Organizations (CROs) estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Regional marketplace outlook, 2024 & 2033, (USD Million)
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Europe RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Germany RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway RNA analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific RNA analysis market estimates and forecast, 2021 - 2033, (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Korea RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 UAE RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Kuwait RNA analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Market position analysis
  • Fig. 98 Market participant categorization
  • Fig. 99 Strategic framework